Case-report: EBV driven lymphoproliferative disorder associated with Ruxolitinib.
(2015) In BMC Hematology 15. p.10-10- Abstract
- Ruxolitinib, a novel inhibitor of Janus kinases 1 and 2, was recently approved for the treatment of myelofibrosis but, recently, attention has been drawn to potential side effects and especially opportunistic infections and virus reactivations. EBV reactivation has not previously been reported to occur in association with Ruxolitinib.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/7749771
- author
- Palmason, Robert LU ; Lindén, Ola LU and Richter, Johan LU
- organization
- publishing date
- 2015
- type
- Contribution to journal
- publication status
- published
- subject
- in
- BMC Hematology
- volume
- 15
- pages
- 10 - 10
- publisher
- BioMed Central (BMC)
- external identifiers
-
- pmid:26167286
- pmid:26167286
- scopus:85013274691
- ISSN
- 2052-1839
- DOI
- 10.1186/s12878-015-0029-1
- language
- English
- LU publication?
- yes
- id
- bc4cae6d-1982-4514-9f40-0b6ae73f8f79 (old id 7749771)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/26167286?dopt=Abstract
- date added to LUP
- 2016-04-04 09:05:11
- date last changed
- 2022-07-03 03:44:27
@article{bc4cae6d-1982-4514-9f40-0b6ae73f8f79, abstract = {{Ruxolitinib, a novel inhibitor of Janus kinases 1 and 2, was recently approved for the treatment of myelofibrosis but, recently, attention has been drawn to potential side effects and especially opportunistic infections and virus reactivations. EBV reactivation has not previously been reported to occur in association with Ruxolitinib.}}, author = {{Palmason, Robert and Lindén, Ola and Richter, Johan}}, issn = {{2052-1839}}, language = {{eng}}, pages = {{10--10}}, publisher = {{BioMed Central (BMC)}}, series = {{BMC Hematology}}, title = {{Case-report: EBV driven lymphoproliferative disorder associated with Ruxolitinib.}}, url = {{http://dx.doi.org/10.1186/s12878-015-0029-1}}, doi = {{10.1186/s12878-015-0029-1}}, volume = {{15}}, year = {{2015}}, }